Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
Clinical trial NCT04348045 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04348045
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2023-06-15
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.